Factor VIII and von Willebrand factor work together at the center of normal clotting. Factor VIII helps build the fibrin clot that seals a damaged blood vessel, while von Willebrand factor helps platelets stick to the injury site and carries factor VIII in the bloodstream so it does not break down too quickly. When one or both are low, the main concern is bleeding, especially nosebleeds, easy bruising, heavy menstrual bleeding, dental bleeding, or bleeding after surgery. When factor VIII or von Willebrand factor is persistently high, the concern shifts toward clot risk, especially venous clots such as deep vein thrombosis or pulmonary embolism.
These tests are often ordered together because the results explain each other. A low factor VIII result can point to hemophilia A, but it can also happen because von Willebrand factor is low or not working properly. A high result may reflect inflammation, pregnancy, stress, age, or an underlying tendency toward clotting.
- Factor VIII activity is usually reported as a percentage or IU/dL; many labs use about 50% to 150% as a typical adult reference range.
- von Willebrand factor antigen measures the amount of VWF protein, while VWF activity measures how well it works.
- Low VWF with bleeding symptoms can suggest von Willebrand disease, especially when VWF activity or antigen is below 30 to 50 IU/dL.
- Low factor VIII with normal VWF can suggest hemophilia A, especially when factor VIII is below 40 IU/dL.
- High factor VIII, often above 150 IU/dL, may increase venous clot risk when it persists outside illness, pregnancy, or inflammation.
- Abnormal results often need repeat testing because VWF and factor VIII can rise temporarily from stress, exercise, infection, inflammation, estrogen, pregnancy, or recent bleeding.
Table of Contents
- How Factor VIII and von Willebrand Factor Work Together
- When These Tests Are Ordered
- Normal Ranges and Result Patterns
- Low Results and Bleeding Risk
- High Results and Clot Risk
- Testing Limitations and Repeat Results
- Follow-Up and Next Steps
How Factor VIII and von Willebrand Factor Work Together
Factor VIII and von Willebrand factor are separate proteins, but they act like a matched pair. Von Willebrand factor, often shortened to VWF, is a large blood protein made mainly by cells lining blood vessels and by platelet-producing cells in the bone marrow. Factor VIII is a clotting factor that circulates in blood bound to VWF.
VWF has two main jobs. First, it helps platelets attach to damaged blood vessel walls, especially in areas where blood flow is fast and shear stress is high. This platelet “plug” is the first layer of clot formation. Second, VWF protects factor VIII from being cleared too quickly from the bloodstream. Without enough functional VWF, factor VIII can fall even when the factor VIII gene itself is normal.
Factor VIII works later in the clotting process. Once activated, it helps factor IX activate factor X, which then supports thrombin generation and fibrin formation. Fibrin acts like a mesh that strengthens the platelet plug. This is why factor VIII deficiency can cause deeper bleeding, while VWF problems often cause mucosal bleeding such as nosebleeds, gum bleeding, heavy menstrual bleeding, and prolonged bleeding after dental work.
The overlap matters because a single abnormal result can have more than one explanation. A low factor VIII activity result may come from hemophilia A, but it may also come from low VWF. A low VWF activity result may reflect a low amount of VWF, a poorly functioning VWF protein, or a subtype of von Willebrand disease that needs specialized testing.
A basic coagulation panel may show a prolonged aPTT when factor VIII is low enough, but many people with mild VWF or factor VIII abnormalities have a normal PT, INR, and aPTT. Normal screening tests do not fully rule out a mild inherited bleeding disorder.
When These Tests Are Ordered
Doctors usually order factor VIII and VWF tests when the bleeding history does not match routine labs, when there is a family history of bleeding, or when a clotting specialist needs to separate inherited bleeding risk from temporary changes caused by illness or inflammation.
Common reasons include:
- frequent or prolonged nosebleeds
- easy bruising, especially large bruises without clear injury
- heavy menstrual bleeding, flooding, or iron deficiency from menstrual blood loss
- prolonged bleeding after dental extraction, surgery, childbirth, or injury
- a family history of von Willebrand disease, hemophilia A, or unexplained bleeding
- a prolonged aPTT that needs explanation
- evaluation before high-risk surgery in someone with a bleeding history
- evaluation after an unusual or recurrent venous clot, especially if factor VIII is suspected to be persistently high
A focused bleeding history is often more useful than a single lab value. Bleeding after wisdom tooth removal, tonsil surgery, childbirth, circumcision, or repeated dental procedures can reveal a disorder that routine blood tests missed. Heavy menstrual bleeding is also important. It can be the first major clue to VWF deficiency, especially when it begins soon after periods start or causes low ferritin or anemia.
Clot history matters too. Factor VIII and VWF can rise after a clot because the body is inflamed or stressed, so testing during or soon after a clot can be hard to interpret. Persistently high factor VIII may be more meaningful when measured after recovery and away from acute illness.
If a prolonged aPTT is the reason for testing, the next step may include an aPTT mixing study. A mixing study helps separate a possible factor deficiency from an inhibitor, such as a lupus anticoagulant or a factor VIII inhibitor.
Normal Ranges and Result Patterns
Reference ranges vary by laboratory, method, age, blood type, pregnancy status, and clinical setting. Many labs report factor VIII and VWF in IU/dL, IU/mL, or percent activity. In practical terms, 100 IU/dL is often similar to 100%, and 0.50 IU/mL is often similar to 50 IU/dL.
Most adult reference intervals fall roughly in these ranges:
| Test | Common reference pattern | Plain-language meaning |
|---|---|---|
| Factor VIII activity | About 50–150 IU/dL or 50%–150% | Measures how well factor VIII supports clot formation |
| VWF antigen | Often about 50–200 IU/dL | Measures the amount of von Willebrand factor protein |
| VWF activity | Often about 50–200 IU/dL | Measures how well VWF binds platelets or related test targets |
| VWF activity-to-antigen ratio | Often expected to be about 0.7 or higher | A low ratio suggests VWF is present but not working normally |
The factor VIII result is best understood beside the VWF results. A standalone factor VIII activity result can show whether activity is low, normal, or high, but the VWF antigen and VWF activity explain whether VWF is contributing to the pattern.
Several result patterns are especially useful:
| Pattern | Possible meaning | Usual follow-up |
|---|---|---|
| Low VWF antigen, low VWF activity, low or low-normal factor VIII | Possible type 1 von Willebrand disease or low VWF | Repeat testing, bleeding history, family history, VWD panel |
| Normal or mildly low VWF antigen, much lower VWF activity | Possible type 2 von Willebrand disease | VWF ratio, multimer testing, subtype testing |
| Very low factor VIII with normal VWF antigen and activity | Possible hemophilia A or factor VIII inhibitor | Repeat factor VIII, mixing study, inhibitor testing if needed |
| Low factor VIII with abnormal VWF binding pattern | Possible type 2N von Willebrand disease | Specialized VWF-factor VIII binding or genetic testing |
| High factor VIII and high VWF | Inflammation, stress, pregnancy, estrogen effect, aging, or increased clot risk if persistent | Repeat when well; assess clot history and other risks |
The von Willebrand disease panel usually includes VWF antigen, VWF activity, and factor VIII activity. Depending on the pattern, the laboratory or hematologist may add VWF collagen binding, VWF multimer analysis, ristocetin-induced platelet agglutination, or genetic testing.
Low Results and Bleeding Risk
Low results usually raise concern for bleeding risk, but the type of bleeding depends on which protein is low and how low it is.
Low VWF most often causes mucocutaneous bleeding. This means bleeding from surfaces: nose, gums, uterus, gastrointestinal tract, and skin. People may notice frequent nosebleeds, easy bruising, heavy periods, prolonged bleeding after dental work, or bleeding after childbirth. Joint and deep muscle bleeding are less common, except in severe VWF deficiency or when factor VIII becomes very low.
Low factor VIII can cause a hemophilia-like pattern. Mild deficiency may only appear after surgery, trauma, or dental extraction. Moderate or severe deficiency can cause deep muscle bleeding, joint bleeding, large hematomas, or prolonged bleeding after injury. A low factor VIII activity result deserves careful review because it can reflect hemophilia A, von Willebrand disease, an acquired inhibitor, or a pre-analytical lab issue.
Low VWF and von Willebrand disease
Von Willebrand disease is usually grouped into three broad types.
Type 1 is a partial quantitative deficiency. The body makes VWF, but the amount is lower than expected. VWF antigen and activity usually fall together, and factor VIII may be mildly low or low-normal. Type 1 is the most common form and can range from mild to clinically important.
Type 2 is a qualitative problem. The amount of VWF may be normal or only mildly reduced, but the protein does not work normally. A low VWF activity-to-antigen ratio often points toward type 2. Subtypes include 2A, 2B, 2M, and 2N. Type 2N is important because it reduces VWF binding to factor VIII and can look like mild hemophilia A.
Type 3 is a severe quantitative deficiency. VWF is absent or extremely low, and factor VIII can be very low because it lacks its carrier protein. Bleeding can be severe and may include joint or muscle bleeding.
Many adults fall into a gray zone called “low VWF,” often around 30 to 50 IU/dL. Some people in this range bleed significantly, while others do not. A diagnosis should not rest on the number alone. Bleeding history, family history, repeat testing, blood type, and surgical history all matter.
Low factor VIII and hemophilia A
Hemophilia A is caused by factor VIII deficiency. Severity is often described by factor VIII activity:
- severe: less than 1 IU/dL or less than 1%
- moderate: 1 to 5 IU/dL or 1% to 5%
- mild: more than 5 to less than 40 IU/dL or 5% to 40%
Women and girls can also have low factor VIII, especially if they are carriers with skewed X-chromosome inactivation or other genetic factors. A normal result at one point in life does not always explain a strong bleeding history, especially if VWF and factor VIII were tested during pregnancy, inflammation, estrogen use, or acute stress.
Some acquired conditions can also lower factor VIII or interfere with its action. Acquired factor VIII inhibitor is uncommon but important because it can cause sudden severe bleeding in someone with no lifelong bleeding history. A prolonged aPTT that does not correct on mixing study can suggest an inhibitor.
High Results and Clot Risk
High factor VIII and high VWF do not mean a clot is present, but they can signal a more clot-prone environment. The result is more concerning when the elevation is persistent, clearly above the lab range, and measured when the person is not acutely ill, pregnant, recently injured, or recovering from surgery.
Factor VIII is often considered high when it is above about 150 IU/dL, though cutoffs vary. VWF can also be high above the laboratory’s upper reference limit. Both are acute-phase reactants, meaning they rise in response to inflammation, tissue injury, infection, stress, and changes in the blood vessel lining.
Common causes of high factor VIII or high VWF include:
- recent infection or inflammation
- recent surgery, trauma, bleeding, or hospitalization
- pregnancy and the postpartum period
- estrogen-containing medications or hormone therapy
- older age
- higher body weight
- liver or kidney disease in some settings
- cancer, autoimmune disease, or chronic inflammatory disease
- non-O blood type, because blood type O is associated with lower average VWF levels
High VWF can reflect endothelial activation, meaning the cells lining blood vessels are responding to stress or inflammation. High factor VIII often travels with high VWF because VWF stabilizes factor VIII in circulation.
A persistently high factor VIII activity result has been linked with higher risk of venous thromboembolism, especially deep vein thrombosis and pulmonary embolism. The result should still be interpreted alongside the person’s full risk profile: prior clots, family history, cancer, surgery, immobility, pregnancy, estrogen use, obesity, inflammatory disease, and inherited thrombophilia results when appropriate.
High VWF antigen can also be seen during inflammation and vascular stress. A high VWF antigen result is not treated by lowering VWF directly in routine care. Instead, clinicians look for the cause and decide whether the person’s overall clot risk needs prevention or treatment.
Symptoms of a possible clot need urgent medical evaluation. These include one-sided leg swelling or pain, sudden shortness of breath, chest pain that worsens with breathing, coughing blood, sudden weakness on one side, facial droop, trouble speaking, or sudden severe headache.
Testing Limitations and Repeat Results
Factor VIII and VWF results can change from week to week. A single normal result does not always rule out a mild bleeding disorder, and a single high result does not always prove a chronic clotting tendency.
VWF and factor VIII can rise quickly during physical stress. Exercise, anxiety during blood draw, pain, fever, infection, inflammation, surgery, active bleeding, pregnancy, and estrogen exposure can all push results upward. This can mask low VWF or mild factor VIII deficiency. For example, someone with a true baseline VWF activity of 35 IU/dL may test near-normal during illness or pregnancy.
Blood type also affects VWF. People with blood type O tend to have lower average VWF levels than people with non-O blood types. This does not automatically mean disease, but it can contribute to low-borderline results in someone who also has bleeding symptoms.
Specimen handling matters. Coagulation tests require careful collection in the correct citrate tube, proper filling, timely processing, and appropriate plasma handling. Underfilled tubes, clotting in the sample, heparin contamination, delayed processing, and anticoagulant medications can distort results.
VWF activity testing has also changed over time. Older ristocetin cofactor assays were useful but variable. Newer platelet-binding activity assays, such as VWF:GPIbM or VWF:GPIbR methods, may perform differently. Comparing results from different labs or different methods can be misleading unless the clinician knows which assay was used.
Repeat testing is common when results are borderline or do not match the history. Testing is often most informative when the person is well, not pregnant, not in the immediate postoperative period, and not in the middle of a major inflammatory illness. Hematologists may repeat the panel at least once and sometimes more than once when the bleeding history is strong.
A complete interpretation may also include a VWF activity test, VWF antigen, factor VIII activity, CBC with platelet count, ferritin if menstrual bleeding is heavy, PT/INR, aPTT, fibrinogen, and platelet function testing when the symptoms suggest a platelet disorder. For people with bruising or mucosal bleeding, platelet count and platelet function can be just as important as clotting factors.
Follow-Up and Next Steps
Follow-up depends on the result pattern and the reason testing was done. Mild abnormalities may only require repeat testing and a bleeding plan before procedures. More severe or confusing patterns need hematology review.
For possible low VWF or von Willebrand disease, the next step is usually to confirm the pattern and match it to the bleeding history. A hematologist may ask about nosebleeds, bruising, dental bleeding, heavy menstrual bleeding, childbirth bleeding, surgical bleeding, transfusions, iron deficiency, and family history. Treatment is not based only on the lab value. It depends on the type of VWD, the severity of bleeding, and the situation.
Common treatment tools include desmopressin, tranexamic acid, hormonal treatment for heavy menstrual bleeding, VWF-containing concentrates, recombinant VWF, iron replacement when iron deficiency is present, and procedure-specific plans. Desmopressin can raise VWF and factor VIII in many people with type 1 VWD, but it is not right for everyone. It may be ineffective in type 3 VWD, risky in type 2B VWD, and limited by hyponatremia risk, especially with repeated dosing or high fluid intake.
For low factor VIII, follow-up may include repeat factor VIII activity, VWF testing, family studies, genetic testing, and inhibitor testing when the pattern suggests an acquired inhibitor. People with confirmed hemophilia A or clinically important low factor VIII need clear instructions for injuries, surgery, dental work, and emergency care.
For high factor VIII or VWF, the first step is often to repeat testing later when temporary causes have settled. If the result remains high, clinicians look at the whole clot-risk picture rather than treating the number alone. A person with persistently high factor VIII and a prior unprovoked clot may be managed differently from someone with a high result during pneumonia and no clot history.
Bring these details to a follow-up visit:
- the exact test names, values, units, and reference ranges
- whether the sample was drawn during illness, pregnancy, injury, inflammation, or hospitalization
- current medications, including anticoagulants, aspirin, NSAIDs, hormones, and supplements
- personal history of heavy bleeding, anemia, transfusion, or clots
- family history of bleeding disorders, hemophilia, VWD, or venous clots
- upcoming surgery, dental extraction, childbirth planning, or invasive procedures
Urgent care is appropriate for bleeding that will not stop with pressure, black or bloody stools, vomiting blood, severe headache after injury, sudden large swelling or pain after trauma, heavy vaginal bleeding with dizziness or fainting, or symptoms of a possible clot. Lab interpretation can wait for a scheduled visit; severe bleeding or clot symptoms should not.
References
- ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease 2021 (Guideline)
- ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease 2021 (Guideline)
- Guideline for laboratory diagnosis and monitoring of von Willebrand disease: A joint guideline from the UKHCDO and the BSH 2024 (Guideline)
- Diagnosis and treatment of von Willebrand disease in 2024 and beyond 2024 (Review)
- Clinical and laboratory diagnosis of von Willebrand disease 2026 (Review)
- Plasma levels of coagulation factors VIII and IX and risk of venous thromboembolism: Systematic review and meta-analysis 2023 (Systematic Review)
Disclaimer
Factor VIII and von Willebrand factor results can change with illness, pregnancy, inflammation, medications, and laboratory method, so abnormal or borderline results should be interpreted by a qualified clinician. Seek urgent medical care for severe bleeding, symptoms of a blood clot, chest pain, sudden shortness of breath, fainting, or neurologic symptoms. This information is educational and should not replace individualized medical advice from a hematologist or other licensed healthcare professional.
